COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    pediatric migraine registry | migraine
Previous Study | Return to List | Next Study

Study of Pediatric Migraine: The Pediatric Migraine Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03742024
Recruitment Status : Active, not recruiting
First Posted : November 15, 2018
Last Update Posted : February 5, 2020
University of California, San Francisco
Information provided by (Responsible Party):
Duke University

Brief Summary:
This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.

Condition or disease

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 201 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 20 Months
Official Title: Observational Study of Pediatric Migraine: The Pediatric Migraine Registry
Actual Study Start Date : December 5, 2018
Estimated Primary Completion Date : January 31, 2021
Estimated Study Completion Date : January 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus Genetics related topics: Migraine
MedlinePlus related topics: Migraine

Children and adolescents
Children and adolescents between the ages of 4 and 17 years old (inclusive)

Primary Outcome Measures :
  1. Migraine frequency [ Time Frame: Approximately 12 months ]
    Number of days per month participant experiences migraine

Biospecimen Retention:   Samples With DNA
Whole blood, buccal swab, urine, stool.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   4 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Participants aged 4-17 years old (inclusive) diagnosed with migraine with or without aura will be eligible for participation in this study.

Inclusion Criteria:

  • 4 to 17 years of age inclusive at the time of enrollment visit
  • Meets International Classification of Headache Disorders, 3rd edition criteria for migraine with or without aura
  • Guardian provides informed consent/HIPAA
  • Participant provides assent if developmentally appropriate and required by the institutional review board

Exclusion Criteria:

  • Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03742024

Show Show 19 study locations
Sponsors and Collaborators
Duke University
University of California, San Francisco
Layout table for investigator information
Principal Investigator: Christoph Hornik, MD Duke University
Principal Investigator: Amy Gelfand, MD University of California at San Francisco
Additional Information:

Layout table for additonal information
Responsible Party: Duke University Identifier: NCT03742024    
Other Study ID Numbers: Pro00100205
First Posted: November 15, 2018    Key Record Dates
Last Update Posted: February 5, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases